InsiderTrades

Form 4 for PROK PROKIDNEY CORP.

Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-04 · accession 0000950170-25-015369 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-06 2025-02-04 PROK Pereira Brian JG Dir C - Cnv Deriv $0.00 +81.9K 81.9K New $0
DI 2025-02-06 2025-02-04 PROK Pereira Brian JG Dir C - Cnv Deriv $0.00 +675.2K 675.2K New $0
DM 2025-02-06 2025-02-04 PROK Pereira Brian JG Dir C - Cnv Deriv $0.00 -163.9K 81.9K -67% $0
DMI 2025-02-06 2025-02-04 PROK Pereira Brian JG Dir C - Cnv Deriv $0.00 -1.35M 675.2K -67% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Shares 2025-02-04 C A 81,928 $0.00 81,928 D By Brian J. G. Pereira 2012 Irrevocable Trust — —
2 Common Class A Ordinary Shares 2025-02-04 C A 675,234 $0.00 675,234 I — —
3 Derivative Class B Ordinary Shares 2025-02-04 C D 81,928 $0.00 81,929 D By Brian J. G. Pereira 2012 Irrevocable Trust $0.00 · — to — 81,928 Class A Ordinary Shares (F1) The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis. (F2) The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire.
4 Derivative Class B Ordinary Shares 2025-02-04 C D 675,234 $0.00 675,235 I $0.00 · — to — 675,234 Class A Ordinary Shares (F1) The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis. (F2) The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire.
5 Derivative Common Units in ProKidney LP 2025-02-04 C D 81,928 $0.00 81,929 D By Brian J. G. Pereira 2012 Irrevocable Trust $0.00 · — to — 81,928 Class A Ordinary Shares (F3) The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.
6 Derivative Common Units in ProKidney LP 2025-02-04 C D 675,234 $0.00 675,235 I $0.00 · — to — 675,234 Class A Ordinary Shares (F3) The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.